TrialPanorama/TrialPanorama-database huggingface dataset:
Study 3403863 — Predictive Biomarker (PRD): PCLAF mRNA
Genes: PCLAF; KIAA0101; NS5ATP9; PAF; L5
Study 21288233 — Surrogate Endpoint (SUR): Serum calcium
Study 30833349 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30833349 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 30833349 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-223
Genes: MIR223
Study 11719727 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 9222234 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9063814 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study 3294978 — Surrogate Endpoint (SUR): Blood pressure
Study 16100213 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11501126 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29475784 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16997421 — Surrogate Endpoint (SUR): Blood pressure
Study 9658727 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 9658727 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 23413266 — Surrogate Endpoint (SUR): Blood pressure
Study 21540753 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 21540753 — Surrogate Endpoint (SUR): Blood pressure
Study 14533211 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 8973986 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12061197 — Surrogate Endpoint (SUR): Blood pressure
Study 7428566 — Surrogate Endpoint (SUR): Blood pressure
Study 25211663 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 10321786 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31073102 — Safety Biomarker (SAF): RYR1
Genes: RYR; PPP1R137
Study 15169848 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 15169848 — Safety Biomarker (SAF): Interleukin 1
Study 15169848 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 7981579 — Surrogate Endpoint (SUR): Blood pressure
Study 29428199 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 8538349 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 1651738 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 29694963 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 24483158 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study 23030673 — Surrogate Endpoint (SUR): Blood pressure
Study 25346345 — Predictive Biomarker (PRD): PRTG mRNA
Genes: PRTG
Study 8420303 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 8420303 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 8420303 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30074128 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 24808022 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 24808022 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 22825506 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16160068 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 12694895 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 12694895 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 11057425 — Surrogate Endpoint (SUR): Blood pressure
Study 31570825 — Predictive Biomarker (PRD): TES mRNA
Genes: TES
Study 26896828 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 26896828 — Predictive Biomarker (PRD): TNF-related weak inducer of apoptosis
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study 20808814 — Safety Biomarker (SAF): Hydroxyphenylpyruvate dioxygenase
Genes: HPD; PPD
Study 18845807 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22941872 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31760314 — Predictive Biomarker (PRD): ASNS mRNA
Genes: ASNS; TS11
Study 28720242 — Surrogate Endpoint (SUR): Blood pressure
Study 2889678 — Surrogate Endpoint (SUR): Forced vital capacity
Study 17064611 — Surrogate Endpoint (SUR): Blood pressure
Study 17064611 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 10855346 — Predictive Biomarker (PRD): Hormone receptor
Study 7677827 — Surrogate Endpoint (SUR): Serum calcium
Study 7677827 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 7677827 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 31272709 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 31272709 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 11246842 — Predictive Biomarker (PRD): Hormone receptor
Study 7525240 — Predictive Biomarker (PRD): SLC10A3 mRNA
Genes: SLC10A3; DXS253E; P3
Study 18209510 — Surrogate Endpoint (SUR): Blood pressure
Study 25611116 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 19824413 — Surrogate Endpoint (SUR): Blood pressure
Study 29566128 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 29566128 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28303624 — Surrogate Endpoint (SUR): Blood pressure
Study 28303624 — Surrogate Endpoint (SUR): Serum potassium
Study 24035299 — Surrogate Endpoint (SUR): Forced vital capacity
Study 21406489 — Surrogate Endpoint (SUR): Blood pressure
Study 12768300 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 9091852 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 29223956 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17890876 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 10958127 — Surrogate Endpoint (SUR): Blood pressure
Study 20556559 — Predictive Biomarker (PRD): LOX mRNA
Genes: LOX
Study 15314950 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 25694350 — Surrogate Endpoint (SUR): Serum calcium
Study 17507322 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 12401595 — Surrogate Endpoint (SUR): Blood pressure
Study 26909792 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 26909792 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 30127049 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 27034623 — Surrogate Endpoint (SUR): Blood pressure
Study 18830857 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 14659770 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 14659770 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 14659770 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 14659770 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 14659770 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 8412148 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 8412148 — Predictive Biomarker (PRD): ROPN1L mRNA
Genes: ROPN1L; ASP; RSPH11
Study 25330837 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 12853784 — Surrogate Endpoint (SUR): Urinary oxalate
Study 6087129 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 30713022 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 18060091 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 18060091 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31252598 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 16061839 — Surrogate Endpoint (SUR): Serum testosterone
Study 30778004 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24518152 — Surrogate Endpoint (SUR): Blood pressure
Study 23329572 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 14761123 — Surrogate Endpoint (SUR): Probing pocket depth
Study 27356528 — Surrogate Endpoint (SUR): Blood pressure
Study 27356528 — Surrogate Endpoint (SUR): Serum sodium
Study 27356528 — Surrogate Endpoint (SUR): Serum potassium
Study 15735389 — Surrogate Endpoint (SUR): Serum sodium
Study 7490317 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7490317 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 7247733 — Surrogate Endpoint (SUR): Serum triglycerides
Study 16549997 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 14739683 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study 8839837 — Safety Biomarker (SAF): Interleukin 1
Study 8839837 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8839837 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 27101291 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 10722500 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 1444526 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19655157 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 17585086 — Surrogate Endpoint (SUR): Serum sodium
Study 27677368 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 27677368 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 19479626 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 15319599 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 7803993 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study 3052916 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 11319684 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 11319684 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 9141913 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9141913 — Surrogate Endpoint (SUR): Blood pressure
Study 2446080 — Surrogate Endpoint (SUR): Blood pressure
Study 29861437 — Surrogate Endpoint (SUR): Forced vital capacity
Study 27466602 — Surrogate Endpoint (SUR): Serum testosterone
Study 9089422 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9089422 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study 8478959 — Predictive Biomarker (PRD): SLC25A21 mRNA
Genes: SLC25A21; ODC
Study 16183781 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 16183781 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 16183781 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 16183781 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 8704114 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 31711417 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 31711417 — Surrogate Endpoint (SUR): Blood pressure
Study 18721085 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study 27978537 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 16644631 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study 10657761 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 22426952 — Surrogate Endpoint (SUR): Bone mineral density
Study 20722561 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30573499 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 30695661 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 21737951 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 9203727 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 20413383 — Surrogate Endpoint (SUR): Bone mineral density
Study 24219891 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 24219891 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 24219891 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 16143696 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2208231 — Surrogate Endpoint (SUR): Blood pressure
Study 22843282 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 22843282 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study 9700992 — Surrogate Endpoint (SUR): Blood pressure
Study 18458358 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 10789569 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 10789569 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 10789569 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 30353303 — Predictive Biomarker (PRD): ARSB mRNA
Genes: ARSB
Study 26540079 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 25178112 — Predictive Biomarker (PRD): CCRL2 mRNA
Genes: CCRL2; CCR11; CCR6; CKRX; CRAM; HCR
Study 25178112 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study 25178112 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 20629810 — Surrogate Endpoint (SUR): Blood pressure
Study 21383004 — Surrogate Endpoint (SUR): Blood pressure
Study 17157123 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17157123 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 17157123 — Surrogate Endpoint (SUR): Blood pressure
Study 14748202 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 9528197 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 3219156 — Surrogate Endpoint (SUR): Blood pressure
Study 26879683 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 23038989 — Surrogate Endpoint (SUR): Bone mineral density
Study 21436597 — Surrogate Endpoint (SUR): Blood pressure
Study 19159566 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 7908356 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29404725 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28490337 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 28490337 — Surrogate Endpoint (SUR): Blood pressure
Study 28490337 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9051165 — Predictive Biomarker (PRD): PAG1 mRNA
Genes: PAG1; CBP; PAG
Study 24557989 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 24557989 — Surrogate Endpoint (SUR): Serum potassium
Study 28556432 — Surrogate Endpoint (SUR): Probing pocket depth
Study 18048433 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 18048433 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 18048433 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 27922020 — Surrogate Endpoint (SUR): Blood pressure
Study 23807278 — Surrogate Endpoint (SUR): Forced vital capacity
Study 23248063 — Surrogate Endpoint (SUR): Blood pressure
Study 7677296 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 6972513 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 25870986 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 25870986 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 25525195 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 23081681 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 21729811 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 21729811 — Surrogate Endpoint (SUR): Blood pressure
Study 26576673 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 18433043 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 18433043 — Surrogate Endpoint (SUR): Blood pressure
Study 18433043 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 12663273 — Surrogate Endpoint (SUR): Blood pressure
Study 10217581 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27166171 — Predictive Biomarker (PRD): PPT1 mRNA
Genes: PPT1; CLN1; PPT
Study 29370144 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 29370144 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 15570920 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 15570920 — Safety Biomarker (SAF): Dihydrothymine dehydrogenase
Genes: DPYD
Study 9310275 — Surrogate Endpoint (SUR): Blood pressure
Study 25876351 — Surrogate Endpoint (SUR): Blood pressure
Study 20636965 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 7502516 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 7502516 — Surrogate Endpoint (SUR): Blood pressure
Study 19244040 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 19244040 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study 17578786 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9260367 — Surrogate Endpoint (SUR): Blood pressure
Study 2832287 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 2832287 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 21372003 — Surrogate Endpoint (SUR): Serum uric acid
Study 15353455 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 23283428 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study 16962345 — Surrogate Endpoint (SUR): Forced vital capacity
Study 22821424 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10741701 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 30309839 — Surrogate Endpoint (SUR): Blood pressure
Study 31721185 — Surrogate Endpoint (SUR): Blood pressure
Study 29246361 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study 24636474 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 20093149 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 10408635 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31570105 — Predictive Biomarker (PRD): HNF1A mRNA
Genes: HNF1A; TCF1
Study 31570105 — Predictive Biomarker (PRD): BAX mRNA
Genes: BAX; BCL2L4
Study 31570105 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 31570105 — Monitoring Biomarker (MOI): Cell-free DNA
Study 17635939 — Surrogate Endpoint (SUR): Bone mineral density
Study 2140735 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 23990195 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 22773769 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 15093987 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 9257889 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 9257889 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 31420414 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study 17043961 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 17043961 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 6378437 — Surrogate Endpoint (SUR): Blood pressure
Study 20199178 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20199178 — Surrogate Endpoint (SUR): Blood pressure
Study 20199178 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10029055 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study 30950565 — Predictive Biomarker (PRD): DGAT1 mRNA
Genes: DGAT1; AGRP1; DGAT
Study 30950565 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 9815633 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 26214555 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17912501 — Safety Biomarker (SAF): DRD2
Study 15868614 — Predictive Biomarker (PRD): MAF mRNA
Genes: MAF
Study 15868614 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 28017706 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study 8033544 — Predictive Biomarker (PRD): SIGLEC12 mRNA
Genes: SIGLEC12; SIGLECL1; SLG; UNQ9215/PRO34042
Study 27986412 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 14666025 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 14666025 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 14666025 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 26118315 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 26118315 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 24934242 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 11555126 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 8185469 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 3237594 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 17179023 — Surrogate Endpoint (SUR): Blood pressure
Study 11230831 — Surrogate Endpoint (SUR): Blood pressure
Study 3402355 — Surrogate Endpoint (SUR): Blood pressure
Study 31418585 — Surrogate Endpoint (SUR): Serum creatinine
Study 31418585 — Surrogate Endpoint (SUR): Bone mineral density
Study 31418585 — Surrogate Endpoint (SUR): Serum calcium
Study 28493932 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 23545150 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 9741655 — Predictive Biomarker (PRD): HBB mRNA
Genes: HBB
Study 8059044 — Surrogate Endpoint (SUR): Forced vital capacity
Study 28632865 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 26156277 — Surrogate Endpoint (SUR): Blood pressure
Study 2184133 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 21703848 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3